Stay updated on XmAb20717 in Biliary Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.

Latest updates to the XmAb20717 in Biliary Cancers Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedAn NIH transition notice was added, directing visitors to updates and FAQs and noting that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check21 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check42 days agoChange DetectedOn 2026-09-21 the record was updated to Completed and new sections for Study Design, Study Status, and Recruitment Status were added. The previous 2025-09-15 entry 'Active, not recruiting' was removed.SummaryDifference0.7%

- Check49 days agoChange DetectedA new revision entry labeled v3.7.0 appears in the study's record history, replacing the previous revision. This indicates an update to the study record's version metadata.SummaryDifference0.1%

Stay in the know with updates to XmAb20717 in Biliary Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.